Variable | Overall (n = 64) | Non-pseudotumor (n = 42) | Pseudotumor (n = 22) | P value | Effect size |
---|---|---|---|---|---|
Age at surgery* | 58.0 ± 9.8 | 60.2 ± 10.0 | 54.0 ± 8.2 | 0.029 | 0.29†|
Gender (female: male) | 54: 10 | 37: 5 | 17: 5 | 0.292 | n/a |
Diagnosis (OA: ION) | 58: 6 | 40: 2 | 18: 4 | 0.169 | n/a |
BMI (kg/m2)* | 22.3 ± 3.0 | 22.7 ± 2.9 | 21.6 ± 2.9 | 0.109 | n/a |
Preoperative hip extension limitation (+ : -)†††| (16: 48) | (7: 35) | (9: 13) | 0.033 | 0.27††|
Head material (metal: ceramic) | 34: 30 | 22: 20 | 12: 10 |  > 0.999 | n/a |
Cup diameter (mm)* | 50.9 ± 2.5 | 50.8 ± 2.5 | 51.2 ± 2.5 | 0.620 | n/a |
Polyethylene liner thickness (mm)* | 6.9 ± 1.3 | 6.8 ± 1.3 | 7.0 ± 1.4 | 0.471 | n/a |
HHS (points)* | 87.2 ± 5.9 | 89.6 ± 5.8 | 85.4 ± 6.7 | 0.184 | n/a |
Cup inclination (°) at 5y* | 42.9 ± 6.0 | 43.7 ± 5.9 | 41.4 ± 6.1 | 0.242 | n/a |
Cup inclination (°) at 15y* | 45.4 ± 5.8 | 45.7 ± 5.9 | 44.7 ± 5.4 | 0.625 | n/a |
Change in cup inclination between 5 and 15y (°)* | 2.4 ± 2.1 | 2.0 ± 1.6 | 3.3 ± 2.6 | 0.025 | 0.28†|
Cup anteversion (°) at 5y* | 16.6 ± 10.3 | 15.9 ± 10.7 | 18.0 ± 9.4 | 0.466 | n/a |
Cup anteversion (°) at 15y* | 20.2 ± 10.8 | 18.7 ± 11.2 | 23.4 ± 9.0 | 0.096 | n/a |
Change in cup anteversion between 5 and 15y (°)* | 3.7 ± 2.6 | 2.9 ± 1.9 | 5.4 ± 2.8 | 0.001 | 0.43†|
PT (°) at 5 y* | 10.9 ± 6.5 | 10.4 ± 7.3 | 11.9 ± 4.5 | 0.336 | n/a |
PT (°) at 15 y* | 16.1 ± 6.9 | 14.5 ± 6.4 | 19.0 ± 6.7 | 0.041 | 0.26†|
Change in PT between 5 and 15y (°)** | 5.2 ± 3.8 | 4.1 ± 2.9 | 7.2 ± 4.5 | 0.008 | 0.33†|
Frequency of osteolysis (cup) | 15 (23%) | 6 (14%) | 9 (41%) | 0.028 | 0.33††|
Frequency of osteolysis (stem) | 14 (22%) | 6 (14%) | 8 (36%) | 0.058 | n/a |
Cobalt ion level (μg/L)** | 0.2 (0.2–0.3) | 0.2 (0.2–0.3) | 0.3 (0.2–0.5) | 0.200 | n/a |
Chromium ion level (μg/L)** | 0.3 (0.2–0.4) | 0.3 (0.2–0.4) | 0.4 (0.3–0.5) | 0.259 | n/a |
Cobalt chrome ratio** | 1.0 (0.6–1.2) | 1.0 (0.5–1.0) | 1.0 (0.8–1.3) | 0.248 | n/a |